10-K Decoder · All companies

Rhythm Pharmaceuticals, Inc.

RYTM · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$190M$130M+45.8%
Operating income−$192M−$266M+27.7%
Net income−$202M−$265M+23.7%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 3, 2026

$Q3 2026Year earlierChange
Revenue$92.1M$51.3M+79.5%
Operating income−$39.3M−$52.7M+25.4%
Net income−$41.4M−$52.9M+21.7%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Rhythm Pharmaceuticals's revenue in FY2025?
$190M in FY2025 (Fiscal year ended Dec 31, 2025), +45.8% vs $130M a year earlier, per its 10-K filed Feb 2026.
Was Rhythm Pharmaceuticals profitable in FY2025?
No: net income was −$202M and operating income −$192M in FY2025.
What was Rhythm Pharmaceuticals's revenue in Q3 2026?
$92.1M (+79.5% vs a year earlier), per its Form 10-Q filed Nov 3, 2026.